163 related articles for article (PubMed ID: 11821626)
1. Natriuretic peptides and salt sensitivity: endocrine cardiorenal integration in heart failure.
Villarreal D; Freeman RH; Reams GP
Congest Heart Fail; 2002; 8(1):29-36, 48. PubMed ID: 11821626
[TBL] [Abstract][Full Text] [Related]
2. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
3. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
4. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure.
Saito H; Ogihara T; Nakamaru M; Hara H; Higaki J; Rakugi H; Tateyama H; Minamino T; Iinuma K; Kumahara Y
Clin Pharmacol Ther; 1987 Aug; 42(2):142-7. PubMed ID: 2955995
[TBL] [Abstract][Full Text] [Related]
6. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides in the pathophysiology of congestive heart failure.
Chen HH; Burnett JC
Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
[TBL] [Abstract][Full Text] [Related]
8. The modulating actions of sulfonylurea on atrial natriuretic peptide release in experimental acute heart failure.
Chen HH; Oh KY; Terzic A; Burnett JC
Eur J Heart Fail; 2000 Mar; 2(1):33-40. PubMed ID: 10742701
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide: water and electrolyte homeostasis.
Kenyon CJ; Jardine AG
Baillieres Clin Endocrinol Metab; 1989 Aug; 3(2):431-50. PubMed ID: 2560911
[TBL] [Abstract][Full Text] [Related]
10. The renal paracrine peptide system--possible urologic implications of urodilatin.
Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
[TBL] [Abstract][Full Text] [Related]
11. The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man.
Struthers AD
Br J Clin Pharmacol; 1992 Jul; 34(1):21-4. PubMed ID: 1385970
[No Abstract] [Full Text] [Related]
12. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
13. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists.
Johnston CI; Hodsman PG; Kohzuki M; Casley DJ; Fabris B; Phillips PA
Am J Med; 1989 Dec; 87(6B):24S-28S. PubMed ID: 2532457
[TBL] [Abstract][Full Text] [Related]
14. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
Zimmerman RS; Schirger JA; Edwards BS; Schwab TR; Heublein DM; Burnett JC
Circ Res; 1987 Jul; 61(1):63-9. PubMed ID: 2955951
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experiences with atrial natriuretic factor].
Brunner HR; Biollaz J; Waeber B; Nussberger J
Schweiz Med Wochenschr; 1987 Dec; 117(49):1937-40. PubMed ID: 2962282
[TBL] [Abstract][Full Text] [Related]
16. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide.
Di Nicolantonio R; Morgan TO
Clin Exp Hypertens A; 1987; 9(1):19-32. PubMed ID: 2953509
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide and its potential role in pharmacotherapy.
Deutsch A; Frishman WH; Sukenik D; Somer BG; Youssri A
J Clin Pharmacol; 1994 Dec; 34(12):1133-47. PubMed ID: 7738207
[TBL] [Abstract][Full Text] [Related]
18. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
19. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
20. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
